Since mitochondrial fission is widely recognized to be directly associated with tumorigenic phenotypes, in the last couple of years, the role of DRP1 in cancer biology was extensively investigated in different types of tumors, such as pancreatic, breast, colorectal, lung, liver, prostate, and ovarian cancer. Here, DNM1L is linked to ovarian cancer.